Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23825459 | 0.88 | — | — | |
| SCHEMBL23825390 | 0.83 | TSHR (0.34) | — | |
| SCHEMBL23825357 | 0.82 | KDM4E (0.36) | KDM4ETDP1 | |
| SCHEMBL23827007 | 0.82 | KDM4E (0.36) | KDM4ETDP1 | |
| SCHEMBL23825318 | 0.81 | KDM4E (0.38) | KDM4ETDP1 | |
| SCHEMBL23825440 | 0.78 | — | — | |
| SCHEMBL23827020 | 0.78 | KDM4E (0.36) | KDM4ETDP1 | |
| SCHEMBL23825340 | 0.76 | — | — | |
| SCHEMBL23825453 | 0.69 | KDM4E (0.30) | KDM4ETDP1 | |
| SCHEMBL6028313 | 0.69 | TSHR (0.32) | TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3882234-B1 | COBALT COMPLEX, METHOD FOR MANUFACTURING SAME, AND METHOD FOR MANUFACTURING COBALT-CONTAINING THIN FILM | TOSOH CORP (JP) | 2024-05-08 | — | — | EP | disclosed |
| US-11753429-B2 | Cobalt complex, method for manufacturing same, and method for manufacturing cobalt-containing thin film | TOSOH CORPORATION (JP) | 2023-09-12 | — | — | US | disclosed |
| CN-112839924-B | Cobalt complex, method for producing same, and method for producing cobalt-containing thin film | 东曹株式会社 | 2023-07-07 | — | — | CN | disclosed |
| US-20220017553-A1 | COBALT COMPLEX, METHOD FOR MANUFACTURING SAME, AND METHOD FOR MANUFACTURING COBALT-CONTAINING THIN FILM | SAGAMI CHEMICAL RESEARCH INSTITUTE (JP) | 2022-01-20 | — | — | US | disclosed |
| EP-3882234-A1 | COBALT COMPLEX, METHOD FOR MANUFACTURING SAME, AND METHOD FOR MANUFACTURING COBALT-CONTAINING THIN FILM | Tosoh Corporation (JP) | 2021-09-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220017553-A1 | COBALT COMPLEX, METHOD FOR MANUFACTURING SAME, AND METHOD FOR MANUFACTURING COBALT-CONTAINING THIN FILM | CNOT9, OR10J3, MRPL9 | KDM4E 2161/4885TDP1 4509/4885 |
| US-11753429-B2 | Cobalt complex, method for manufacturing same, and method for manufacturing cobalt-containing thin film | OR10J3, CNOT9, RNF10 | KDM4E 1839/4885TDP1 4679/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.